ZAROXOLYN SUMMARY
ZAROXOLYN Tablets (metolazone tablets, USP) for oral administration contain 2 ½, 5, or 10 mg of metolazone, USP, a diuretic/saluretic/antihypertensive drug of the quinazoline class.
ZAROXOLYN is indicated for the treatment of salt and water retention including:
-
edema accompanying congestive heart failure;
-
edema accompanying renal diseases, including the nephrotic syndrome and states of diminished renal function.
ZAROXOLYN is also indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs of a different class. MYKROX Tablets, a more rapidly available form of metolazone, are intended for the treatment of new patients with mild to moderate hypertension. A dose titration is necessary if MYKROX Tablets are to be substituted for ZAROXOLYN in the treatment of hypertension. See package circular for MYKROX Tablets (Celltech).
|
